IDV vehicle
75N95025D00003
GMP SYNTHESIS OF BULK DRUG SUBSTANCES. THIS IDIQ CONTRACT SHALL HAVE A 5-YEAR ORDERING PERIOD FROM MARCH 14, 2025 THROUGH MARCH 13, 2030.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $10.0M |
| Start date | Mar 14, 2025 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Mar 14, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 14, 2025 | 0 | $0 | GMP SYNTHESIS OF BULK DRUG SUBSTANCES. THIS IDIQ CONTRACT SHALL HAVE A 5-YEAR ORDERING PERIOD FROM MARCH 14, 2025 THROUGH MARCH 13, 2030. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Polina Klimenkova | Contact | polina.klimenkova@nih.gov 3018276848 | Source | Mar 20, 2024 |
| Rob Bailey | Contact | Rob.Bailey@nih.gov 3014517586 | Source | Mar 20, 2024 |
| Polina Klimenkova | Contact | polina.klimenkova@nih.gov 3018276848 | Source | Mar 4, 2024 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3018276923 | Source | Mar 4, 2024 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.